Although we did not evaluate G6PD gene expression in MYCN-amplified neuroblastoma cells, it was reported that MYCN levels were correlated with altered expression of proteins involved in enhanced glycolysis and increased oxidative phosphorylation [13]. The gene discussed is G6PD; the disease is neuroblastoma.